サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1363069

呼吸器疾患検査の市場規模、シェア、動向分析レポート：製品別、最終用途別、用途別、地域別、セグメント別予測、2023年～2030年

Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 90 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
呼吸器疾患検査の市場規模、シェア、動向分析レポート：製品別、最終用途別、用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月18日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

呼吸器疾患検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の呼吸器疾患検査市場規模は、2023年から2030年にかけてCAGR 2.8％で成長し、2030年までに77億5,000万米ドルに達すると予測されています。

この市場を牽引しているのは、呼吸器疾患の有病率の上昇です。国際呼吸器学会フォーラムによると、2014年には世界中で2億人以上が慢性閉塞性肺疾患（COPD）に罹患し、2億3,500万人が喘息に苦しんでいます。さらに、年間5000万人以上が職業性肺疾患に苦しんでいるとのことです。このように、対象となる患者人口が絶えず増加していることが、成長を促進すると予想されています。

COPD診断のためのコンピュータ断層撮影（CT）などの革新的技術の採用は、成長を促進すると予想されます。COPDの急性期医療管理におけるその他の新技術は、外来患者のモニタリングに使用されるパルスオキシメータです。気道管理はCOPDの検査と管理において主要な役割を果たします。また、最近の技術革新により、COPD管理のための非侵襲的機械的換気（NIV）の使用が12.1％増加しています。技術の進歩とともに、呼吸器疾患検査/診断市場では、デジタルX線撮影（X線）と高度な携帯型スパイロメータの使用が勢いを増しています。

呼吸器疾患検査市場のレポートハイライト

  • 呼吸器疾患の有病率の増加と急速な技術進歩は、市場成長を促進すると予想される主要因の2つです。
  • 製品別では、革新的技術の急速な開発と採用により、画像検査が2022年に最大のシェアを占めました。
  • 用途別では、結核が世界の有病率の上昇により2022年に最大市場となっています。
  • 最終用途別では、病院分野が2022年に最大のシェアを占め、入院の増加や病院での治療に対する嗜好の高まりにより、予測期間中に成長すると予測されます。
  • 北米は2022年に呼吸器疾患検査市場を独占しました。COPD、喘息などの呼吸器疾患の有病率の増加、早期診断の需要の増加、早期診断の利点に関する患者の意識の高まりが優位性の要因です。
  • アジア太平洋地域は予測期間中に最も速い速度で成長すると予想されます。この成長は、ヘルスケアインフラの改善や、COPDや喘息などの呼吸器疾患に対する新しい診断技術の利用可能性に関する患者の意識の高まりなど、さまざまな要因によるものです。
  • この市場で競合している主要企業には、Becton Dickinson（Carefusion Corporation）、Koninklijke Philips N.V.（Respironics）、ResMed Company、Fischer &Paykel、Medtronicなどがあるが、これらに限定されるものではないです。これらの企業は呼吸器疾患診断市場において精巧な製品ポートフォリオを有しており、市場における強力なブランドです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 呼吸器疾患検査市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 呼吸器疾患検査市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 呼吸器疾患検査：製品の推定・動向分析

  • 呼吸器疾患検査市場：重要なポイント
  • 呼吸器疾患検査市場：動向と市場シェア分析、2022年および2030年
  • 画像検査
    • 画像検査市場推計・予測、2018年から2030年まで
  • 呼吸測定装置
    • 呼吸測定装置市場推計・予測、2018年から2030年まで
  • 血液ガス検査
    • 血液ガス検査市場推計・予測、2018年から2030年まで
  • その他
    • その他の市場推計・予測、2018年から2030年まで

第5章 呼吸器疾患検査：適用推定・動向分析

  • 呼吸器疾患検査市場：重要なポイント
  • 呼吸器疾患検査市場：動向と市場シェア分析、2022年および2030年
  • 慢性閉塞性肺疾患
  • 肺がん
  • 喘息
  • 結核
  • その他

第6章 呼吸器疾患検査：最終使用推定・動向分析

  • 呼吸器疾患検査市場：重要なポイント
  • 呼吸器疾患検査市場：動向と市場シェア分析、2022年および2030年
  • 病院
    • 病院市場推計・予測、2018年から2030年まで
  • 医師の診療所
    • 医師の診療所市場推計・予測、2018年から2030年まで
  • 臨床検査室
    • 臨床検査市場推計・予測、2018年から2030年まで
  • その他
    • その他の市場推計・予測、2018年から2030年まで

第7章 呼吸器疾患検査市場：地域推定・動向分析

  • 地域別の展望
  • 地域別の呼吸器疾患検査市場：マーケットプレースにおける重要なポイント
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Abbott
    • BD
    • Koninklijke Philips N.V.
    • ResMed
    • Fisher & Paykel Appliances Ltd
    • Medtronic
    • BIOMERIEUX
    • Carestream Health
    • SDI Diagnostics
    • Siemens Healthcare GmbH
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 23 France respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 24 France respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 48 China respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 49 China respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 51 India respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 52 India respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Thailand respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 54 Thailand respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Thailand respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Australia respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 60 Australia respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Respiratory disease testing: Market outlook
  • Fig. 9 Respiratory disease testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Respiratory disease testing market driver impact
  • Fig. 15 Respiratory disease testing market restraint impact
  • Fig. 16 Respiratory disease testing market strategic initiatives analysis
  • Fig. 17 Respiratory disease testing market: Product movement analysis
  • Fig. 18 Respiratory disease testing market: Product outlook and key takeaways
  • Fig. 19 Imaging tests market estimates and forecasts, 2018 - 2030
  • Fig. 20 Respiratory measurement devices market estimates and forecasts, 2018 - 2030
  • Fig. 21 Blood gas test market estimates and forecasts, 2018 - 2030
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030
  • Fig. 23 Respiratory disease testing market: Application movement analysis
  • Fig. 24 Respiratory disease testing market: Application outlook and key takeaways
  • Fig. 25 Chronic obstructive pulmonary disease market estimates and forecasts, 2018 - 2030
  • Fig. 26 Lung cancer market estimates and forecasts, 2018 - 2030
  • Fig. 27 Asthma market estimates and forecasts, 2018 - 2030
  • Fig. 28 Tuberculosis market estimates and forecasts, 2018 - 2030
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030
  • Fig. 30 Respiratory disease testing market: End-use movement analysis
  • Fig. 31 Respiratory disease testing market: End-use outlook and key takeaways
  • Fig. 32 Hospital market estimates and forecasts, 2018 - 2030
  • Fig. 33 Physicians clinic market estimates and forecasts, 2018 - 2030
  • Fig. 34 Clinical laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030
  • Fig. 36 Global Respiratory Disease Testing Market: Regional Movement Analysis
  • Fig. 37 Global Respiratory disease testing market: Regional outlook and key takeaways
  • Fig. 38 North America market estimates and forecasts, 2018 - 2030
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 41 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 44 France market estimates and forecasts, 2018 - 2030
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 47 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 52 China market estimates and forecasts, 2018 - 2030
  • Fig. 53 India market estimates and forecasts, 2018 - 2030
  • Fig. 54 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 55 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 56 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 57 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 58 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 59 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 60 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 61 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 63 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 64 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-1-68038-807-7

Respiratory Disease Testing Market Growth & Trends:

The global respiratory disease testing market size is expected to reach USD 7.75 billion by 2030, registering a CAGR of 2.8% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market is driven by the rising prevalence of respiratory diseases. As per Forum of International Respiratory Societies, more than 200 million people across the globe suffered from Chronic Obstructive Pulmonary Disease (COPD) and 235 million suffered from asthma in 2014. In addition, the source stated that more than 50 million people struggle with occupational lung diseases annually. Thus, constantly growing target patient population is anticipated to drive the growth.

The adoption of innovative technologies, such as Computed Tomography (CT), for COPD diagnosis is expected to drive the growth. The other new technology in acute medical management of COPD is pulse oximeter that is used for outpatient monitoring. Airway management plays a main role in testing and management of COPD. Also, with recent technological innovations, there has been a 12.1 % increase in the use of Noninvasive Mechanical Ventilation (NIV) for management of COPD. Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the respiratory disease testing/diagnostics market.

Respiratory Disease Testing Market Report Highlights:

  • Growing prevalence of respiratory diseases and rapid technological advancements are two of the major factors expected to propel the market growth
  • Based on products, imaging tests held the largest share in 2022 due to rapid development and adoption of innovative technologies
  • Based on application, tuberculosis was the largest market in 2022 owing to rising prevalence of the disease globally
  • Based on end-use, hospitals segment held the largest share in 2022 and is anticipated to grow over the forecast period due to an increase in hospitalization and a growing preference for hospital treatment
  • North America dominated the respiratory disease testing market in 2022. Growing prevalence of respiratory diseases such as COPD, & asthma, increasing demand for early diagnosis, and rising awareness amongst patients about the benefits of early diagnosis are responsible for the dominance
  • Asia Pacific region is expected to grow at the fastest rate during the forecast period. This growth can be attributed to various factors, such as improving healthcare infrastructure and increasing patient awareness regarding the availability of new diagnostic techniques for respiratory diseases, such as COPD & asthma
  • Some of the major players competing in this market include, but are not limited to, Becton Dickinson (Carefusion Corporation); Koninklijke Philips N.V. (Respironics); ResMed Company; Fischer & Paykel; and Medtronic. These players are strong brands in the market as they have elaborate product portfolios in respiratory disease diagnostics market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Respiratory Disease Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Respiratory Disease Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Respiratory Disease Testing: Product Estimates & Trend Analysis

  • 4.1. Respiratory Disease Testing Market: Key Takeaways
  • 4.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Imaging Tests
    • 4.3.1. Imaging tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Respiratory Measurement devices
    • 4.4.1. Respiratory measurement devices market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Blood Gas Test
    • 4.5.1. Blood gas test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Respiratory Disease Testing: Application Estimates & Trend Analysis

  • 5.1. Respiratory Disease Testing Market: Key Takeaways
  • 5.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Chronic Obstructive Pulmonary Disease
    • 5.3.1. Chronic obstructive pulmonary disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Lung Cancer
    • 5.4.1. Lung cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Asthma
    • 5.5.1. Asthma market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Tuberculosis
    • 5.6.1. Tuberculosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Respiratory Disease Testing: End-use Estimates & Trend Analysis

  • 6.1. Respiratory Disease Testing Market: Key Takeaways
  • 6.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospital
    • 6.3.1. Hospital market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Physicians Clinic
    • 6.4.1. Physician clinic market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Clinical Laboratories
    • 6.5.1. Clinical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Respiratory Disease Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Respiratory Disease Testing Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Abbott
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. BD
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Koninklijke Philips N.V.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. ResMed
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Fisher & Paykel Appliances Ltd
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Medtronic
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. BIOMERIEUX
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Carestream Health
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. SDI Diagnostics
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Siemens Healthcare GmbH
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives